Imprimis Pharmaceuticals, Inc. (IMMY) stock prices updated...

Imprimis Pharmaceuticals, Inc. stock price

Imprimis Pharmaceuticals, Inc. latest news:

  • 01/24/2018 05:33:07

    BRIEF-Imprimis Pharmaceuticals Is Issued DEA Manufacturer Certificate For Its 503B Outsourcing Facility

    Imprimis Pharmaceuticals Inc(IMMY): * IMPRIMIS PHARMACEUTICALS IS ISSUED DEA MANUFACTURER CERTIFICATE FOR ITS 503B OUTSOURCING FACILITY Source text for Eikon: Further company coverage:

  • 01/16/2018 14:59:57

    Imprimis receives FDA warning over eye medication advertising

    The U.S. Food and Drug Administration has issued a warning letter to Imprimis Pharmaceuticals Inc (IMMY) accusing it of making false or misleading claims that its compounded eye medications had the agency's approval. The Dec. 21 letter to San Diego-based Imprimis was posted on the FDA's website on Tuesday.

  • More trends:

    INC Research Holdings, Inc.INCR | inContact, Inc.SAAS | Incyte CorporationINCY | Independent Bank Corp.INDB | Independent Bank CorporationIBCP | Independent Bank Group, IncIBTX | Industrial Services of America, Inc.IDSA | Infinera CorporationINFN | Infinity Pharmaceuticals, Inc.INFI | Infinity Property and Casualty CorporationIPCC |